Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Califano, D."'
Autor:
Capoluongo ED, B, Pellegrino, Arenare L, Califano D, Scambia G, L, Beltrame, V, Serra, Scaglione GL, Spina A, Cecere SC, De Cecio R, N, Normanno, N, Colombo, Lorusso D, Russo D, Nardelli C, M, D'Incalci, Llop-Guevara A, Pisano C, G, Baldassarre, Mezzanzanica D, Artioli G, Setaro M, Tasca G, C, Roma, Campanini N, Cinieri S, A, Sergi, Musolino A, Perrone F, Chiodini P, S, Marchini, Pignata S
Publikováno v:
Scientia
Molecular testing; Ovarian cancer Proves moleculars; Càncer d'ovaris Pruebas moleculares; Cáncer de ovarios Background The detection of homologous recombination deficiency (HRD) can identify patients who are more responsive to platinum and poly ADP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf39ab4ed238d4e922aed12d4c930dd
https://hdl.handle.net/11351/8362
https://hdl.handle.net/11351/8362
Autor:
Crescenzo D’Alterio, Anna Spina, Laura Arenare, Paolo Chiodini, Maria Napolitano, Francesca Galdiero, Luigi Portella, Vittorio Simeon, Simona Signoriello, Francesco Raspagliesi, Domenica Lorusso, Carmela Pisano, Nicoletta Colombo, Gian Franco Zannoni, Nunzia Simona Losito, Rossella De Cecio, Giosuè Scognamiglio, Daniela Califano, Daniela Russo, Valentina Tuninetti, Maria Carmela Piccirillo, Piera Gargiulo, Francesco Perrone, Sandro Pignata, Stefania Scala
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1849
This study investigated the prognostic role of the CXCR4-CXCL12-CXCR7 axis in advanced epithelial ovarian cancer (EOC) patients receiving first-line treatment within the MITO16A/MaNGO-OV2 phase-IV trial. CXCR4-CXCL12-CXCR7 expression was evaluated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d26817c3579a3e44a95815dabcbfa3
http://hdl.handle.net/11591/470501
http://hdl.handle.net/11591/470501
Autor:
Gustavo Baldassarre, Nicoletta Colombo, Eliana Bignotti, Vincenzo Canzonieri, Vittorio Simeon, Paolo Chiodini, Sabrina Chiara Cecere, Gian Luca Rampioni Vinciguerra, Daniela Califano, Maria Carmela Piccirillo, Francesca Citron, Giovanni Scambia, Daniela Russo, Marco Montella, Francesco Perrone, Gian Franco Zannoni, Anna Spina, Alessandra Ciucci, Germana Tognon, Clorinda Schettino, Laura Arenare, Nunzia Simona Losito, Michele Del Sesto, Rossella De Cecio, Sandro Pignata, Gabriella Ferrandina, Piera Gargiulo, Giosuè Scognamiglio, Daniela Gallo, Simona Signoriello
Publikováno v:
Cancers, Vol 13, Iss 5152, p 5152 (2021)
Cancers
Volume 13
Issue 20
Cancers
Volume 13
Issue 20
Simple Summary The possibility to identify, with appropriate biomarkers, patients that might mostly benefit from any given treatment is the basis of personalized oncology. Cancer biomarkers should be properly identified and validated on a large numbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7daab41216b40ddd8bfc2c29df9471eb
http://hdl.handle.net/10807/198390
http://hdl.handle.net/10807/198390
Autor:
Sandro Pignata, Gennaro Chiappetta, Nunzia Simona Losito, Stefano Greggi, Veronica De Simone, Adolfo Gallipoli, Rosa Pasquinelli, Carmela Pisano, Alessandro Ottaiano, Giuseppe Laurelli, Alfredo Fusco, Roberto Cirombella, Daniela Califano
Publikováno v:
Journal of cellular physiology
222 (2010): 382–386.
info:cnr-pdr/source/autori:Califano D, Pignata S, Pisano C, Greggi S, Laurelli G, Losito NS, Ottaiano A, Gallipoli A, Pasquinelli R, De Simone V, Cirombella R, Fusco A, Chiappetta G./titolo:FEZ1%2FLZTS1 protein expression in ovarian cancer./doi:/rivista:Journal of cellular physiology (Print)/anno:2010/pagina_da:382/pagina_a:386/intervallo_pagine:382–386/volume:222
222 (2010): 382–386.
info:cnr-pdr/source/autori:Califano D, Pignata S, Pisano C, Greggi S, Laurelli G, Losito NS, Ottaiano A, Gallipoli A, Pasquinelli R, De Simone V, Cirombella R, Fusco A, Chiappetta G./titolo:FEZ1%2FLZTS1 protein expression in ovarian cancer./doi:/rivista:Journal of cellular physiology (Print)/anno:2010/pagina_da:382/pagina_a:386/intervallo_pagine:382–386/volume:222
The FEZ1/LZTS1 (FEZ1) gene maps to chromosome 8p22 and is frequently altered in human cancer. FEZ1 has been proposed as a candidate tumour suppressor gene and its loss may contribute to tumour progression. We have analysed the expression of FEZ1 prot
Autor:
Daniela Califano, Gerardo Botti, Angelo Ferraro, Gennaro Chiappetta, Massimo Santoro, Alfredo Fusco, Giovanna Maria Pierantoni, Francesca Galdiero, Pierlorenzo Pallante, Mario Monaco, Veronica De Simone, Luciano Pezzullo, Emilia Vuttariello
Publikováno v:
European journal of cancer (1990) 44 (2008): 1015–1021. doi:10.1016/j.ejca.2008.02.039
info:cnr-pdr/source/autori:Chiappetta, Gennaro; Ferraro, Angelo; Vuttariello, Emilia; Monaco, Mario; Galdiero, Francesca; De Simone, Veronica; Califano, Daniela; Pallante, Pierlorenzo; Botti, Gerardo; Pezzullo, Luciano; Pierantoni, Giovanna Maria; Santoro, Massimo; Fusco, Alfredo/titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias/doi:10.1016%2Fj.ejca.2008.02.039/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
European journal of cancer (1990) 44 (2008): 1015–1021.
info:cnr-pdr/source/autori:Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A./titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias./doi:/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
info:cnr-pdr/source/autori:Chiappetta, Gennaro; Ferraro, Angelo; Vuttariello, Emilia; Monaco, Mario; Galdiero, Francesca; De Simone, Veronica; Califano, Daniela; Pallante, Pierlorenzo; Botti, Gerardo; Pezzullo, Luciano; Pierantoni, Giovanna Maria; Santoro, Massimo; Fusco, Alfredo/titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias/doi:10.1016%2Fj.ejca.2008.02.039/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
European journal of cancer (1990) 44 (2008): 1015–1021.
info:cnr-pdr/source/autori:Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A./titolo:HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias./doi:/rivista:European journal of cancer (1990)/anno:2008/pagina_da:1015/pagina_a:1021/intervallo_pagine:1015–1021/volume:44
We have analysed the expression of the HMGA2 gene in a panel of normal and neoplastic thyroid tissues by immunohistochemistry and quantitative RT-PCR. HMGA2 protein was detectable in four out of 21 follicular carcinomas, 30 out of 45 papillary carcin
Autor:
Massimo Santoro, Silvia De Gisi, Angela Persico, Donatella Malanga, Gennaro Chiappetta, Carmela De Marco, Maria Letizia Motti, Giancarlo Troncone, Daniela Califano, Giuseppe Viglietto, Simona Losito, Alfredo Fusco, Fernanda Fabiani
Publikováno v:
Cell Cycle. 6:2817-2825
In the present study, we report that the RAS/BRAF/MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of hum
Autor:
Lorenzo Chiariotti, F. de Nigris, Daniela Califano, J. Cerutti, C. Morelli, Alfredo Fusco, Giovanni Santelli, Giuseppe Viglietto
Publikováno v:
Scopus-Elsevier
British Journal of Cancer
British Journal of Cancer
We used subtractive library screening to identify the changes that occur in gene expression during thyroid cell neoplastic transformation. Complementary DNA from normal thyroid cells (HTC 2) was subtracted from a complementary DNA library constructed
Autor:
Daniela Califano, A. Mineo, V de Franciscis, Giancarlo Vecchio, Carmen Monaco, Giovanni Chiappetta, Giovanni Santelli
Publikováno v:
International Journal of Cancer. 63:757-760
We have earlier shown that expression of the human activated Ki-ras, directed by the rat thyroglobulin CTG) promoter in the thyroid gland of transgenic mice, is able to induce thyroid benign tumors, albeit at low incidence. A likely explanation of ou
Autor:
Tullio Florio, Gennaro Schettini, Laura Cerchia, Maria Stella Carlomagno, Daniela Califano, Mariarosaria Incoronato, V de Franciscis, Giovanni Santelli, A D'Alessio
The Src homology 2-containing tyrosine phosphatase, Shp-2, is a crucial enzyme that mediates intracellular signaling and is implicated in cell proliferation and differentiation. Here we investigated the involvement of the Shp-2 tyrosine phosphatase i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac314172b86228b0bd00afff370ab842
http://hdl.handle.net/11567/280561
http://hdl.handle.net/11567/280561
Autor:
Nicole Fabien, Daniela Califano, Angela Celetti, Alfredo Fusco, Christian Paulin, Massimo Santoro, Caterina Battaglia, Maria Luisa Martelli, Carmen Monaco, Giuseppe Viglietto, Domenico Salvatore
Publikováno v:
Scopus-Elsevier
Salvatore D, Celetti A, Fabien N, Paulin C, Martelli ML, Battaglia C, Califano D, Monaco C, Viglietto G, Santoro M, Fusco A. Low frequency of p53 mutations in human thyroid tumors; p53 and Ras mutation in two out of fifty-six thyroid tumours. Eur J E